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Role of Echocardiography in Predicting Onset of Heart
Failure in Patients With Stable Coronary Artery Disease
Is the Whole Greater Than the Sum of its Parts?*
Miguel A. Quinones, MD, FACC
Houston, TexasDespite great improvements in the prevention and
treatment of coronary artery disease (CAD), the
prevalence of heart failure (HF) continues to rise,
and CAD remains a common etiology for this
disorder (1,2). This apparent paradox is partially
explained by the increasing prevalence of risk fac-
tors for HF, including the number of patients
surviving myocardial infarction (MI) with reduced
left ventricular (LV) ejection fraction (EF). The
American College of Cardiology/American Heart
Association (ACC/AHA) 2005 Guideline Update
for the Diagnosis and Management of Chronic
Heart Failure in the Adult classified HF into 4
stages, the first 2 representing subclinical stages that
pre-dispose patients to clinical HF (2). In stage
See page 11
A, patients have major risk factors such as hyperten-
sion, CAD, obesity, or diabetes, without known struc-
tural heart disease; patients in stage B have evidence of
structural heart disease (previous MI, concentric left
ventricular hypertrophy, LV remodeling, or low EF)
that further increases their risk for clinical HF. This
classification allows physicians to introduce preventive
measures to reduce the incidence of HF in populations
at risk. This is of great importance because the first
hospitalization for HF worsens survival for most
patients, regardless of resting EF (3–5). Given that
recognition of stage B HF is facilitated by echocardi-
ography, there has been great interest in exploring the
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Department of Cardiology, Methodist Hospital and the
Methodist DeBakey Heart and Vascular Center, Houston, Texas.prognostic value of echocardiographic findings in
populations at risk for HF.
In this issue of iJACC, Stevens et al. (6) explored
the hypothesis that findings derived from a resting
transthoracic echocardiogram in patients with
CAD can be combined to develop a risk-
stratification index that predicts HF hospitalization.
They studied 1,024 ambulatory subjects participat-
ing in the Heart and Soul Study, all of whom had
clinical characteristics that placed them in stage A
or B heart failure (known CAD, previous MI [6
months], hypertension). More than 80% of the
participants had never experienced a hospitalization
for HF, and the majority (92.7%) had an EF 45%
(mean EF: 62  10%; range: 13% to 83%).
Using the Cox proportional hazard model, the
authors assessed the association of 15 transthoracic
echocardiogram measurements with subsequent HF
hospitalization. Although most of the variables were
identified as predictors of HF hospitalization by univar-
iate analysis, only 5 were independent predictors: mitral
regurgitation (MR), left atrial volume index (LAVI),
LV mass index, the integral of the velocity in the LV
outflow tract by pulsed-wave Doppler (VTILVOT),
and diastolic dysfunction (i.e., pseudonormal or re-
strictive mitral inflow pattern indicative of elevated
filling pressures). The authors applied a point-scoring
system to the 5 variables to develop a HF risk index
(RI) with a scale ranging from 0 to 8 (1 point each
given for  mild MR, LAVI 29 ml/m2, VTILVOT
22 cm; 2 points for diastolic dysfunction; and 3
points for LV mass index 90 g/m2). During an
average follow-up of 4.4 years, HF hospitalizations
were observed in 4% of participants with an RI of 0 to
2 compared with 10% with an RI of 3 to 4 (p 
0.003); 24% with an RI of 5 to 6 (p  0.0001); and
48% with an RI of 7 to 8 (p  0.0001). The
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22ssociation between the RI and HF hospitalization
emained significant even after adjusting for several
omorbidities. Results were similar, but with lower
isks in the 831 participants without a previous history
f HF.
Four of the 5 components of the HFRI have been
dentified previously as predictors of outcome in pa-
ients with CAD and/or LV dysfunction. In MI
urvivors, the presence of functional/ischemic MR,
ven if mild, is associated with higher mortality and
orsening of HF (7). Left atrium (LA) enlargement
nd diastolic dysfunction have been shown to predict
orse outcomes in patients with CAD, hypertension,
nd/or LV dysfunction (8–15). Left ventricular dila-
ion (i.e., eccentric hypertrophy) and concentric hy-
ertrophy are both associated with a greater preva-
ence of cardiovascular events and death, and both are
aptured by measuring LV mass (10,16–18). In fact,
n multiple studies, LV mass consistently appears as
strong independent predictor of outcome. In a
ohort of 1,172 patients enrolled in the SOLVD
Studies Of Left Ventricular Dysfunction) trials
n  577) and registry (n  595), LV mass, LA
ize, and EF were independent predictors of 1-year
ortality and the rate of cardiovascular hospitaliza-
ions (10). Left ventricular mass was a strong
redictor, and at lower ranges, had a protective
ffect irrespective of EF. The fact that close to 98%
f the participants in this study had preserved EF
xplains why this measurement lost power as an
ndependent predictor of HF hospitalization.
Although each of the 5 echocardiographic param-
ters in this study predicted outcome, when combined
nto an HFRI, the prediction of risk was superior to
hat provided by any single parameter. This is a good
xample of “the whole is greater than the sum of its
arts.” There are several examples in medicine in
hich individual parameters are combined into a risk
tratification score; perhaps the most commonly
nown in cardiology is the Framingham Risk Score,
hich combines sex, age, blood pressure, cholesterol
evels, diabetes, and smoking to predict a 10-year risk
f developing CAD (19). Therefore, this concept
akes clinical sense and has a strong statistical basis.
Although the components of the HFRI are com-
only used by clinical echocardiographers, measure-
ent techniques vary between laboratories, and this
ould influence the cut-off values used to determine
he HFRI. The authors measured LA volume with
he biplane method of disc, but other laboratories use
he area-length method; both are endorsed by the
merican Society of Echocardiography (20). How-
ver, normal ranges vary slightly between these meth- 7ds. Similarly, LV mass was measured with the
runcated ellipsoid equation, but other laboratories use
he American Society of Echocardiography modifica-
ion of the cube formula, which has slightly different
ormal ranges. The authors defined pseudonormal
iastolic dysfunction as a peak mitral early diastolic to
trial contraction velocity (E/A) ratio between 0.76
nd 1.4, with diastolic-dominant pulmonary vein
ow, and a restrictive pattern as an E/A 1.5, with
iastolic dominant pulmonary vein flow. These pat-
erns are markers for elevated LV filling pressures and
ere initially described in patients with depressed LV
unction using the E/A ratio and deceleration time
9). However, they are known to lose accuracy in
atients with preserved EF (21). Consequently, most
aboratories currently use the ratio of transmitral
-velocity to early diastolic annular velocity by tissue
oppler (E/E’) to better define these patterns,
articularly in patients with normal EF; an E/E’
15 detects a mean left atrial pressure15 mmHg
nd is a marker of advanced diastolic dysfunction
15,22). This ratio has also been shown to predict
F events in populations at risk (14,15). Using
/E’ to define diastolic dysfunction could have
mportant influence on the HFRI, perhaps by
mproving its predictive accuracy. It may be worth-
hile to investigate this hypothesis prospectively.
Ultimately, the value of any risk stratification
ethod is to identify patients who benefit from
ore aggressive preventive measures. All of the
tudy participants were in stage A or B heart failure
nd would benefit from aggressive management of
heir risk factors (2). Consequently, it is not clear
ow much more is gained by restratifying them
ith an echocardiographic HFRI. Perhaps patients
n stage A with an HFRI 5 would benefit from
eceiving therapy recommended for stages B or C,
articularly if they have evidence of diastolic dys-
unction (i.e., elevated filling pressures). The only
nswer to this question would come from a ran-
omized clinical trial in which 1 group is treated
ased on an HFRI, while the other is managed
ccording to the ACC/AHA guidelines. Until
hen, we should adhere to the ACC/AHA recom-
endations. Nevertheless, the echocardiographic
FRI represents an important step in simplifying
ata from a routine transthoracic echocardiogram
nd using it to enhance our assessment of risk for
eart failure hospitalization in selected patients.
eprint requests and correspondence:Dr. Miguel A. Qui-
ones, Department of Cardiology, Methodist Hospital,
ardiology, 6550 Fannin, Suite 1901, Houston, Texas
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